NO159169C - Analogifremgansmaate for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)eddiksyre med antitumoral terapeutisk aktivitet. - Google Patents

Analogifremgansmaate for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)eddiksyre med antitumoral terapeutisk aktivitet.

Info

Publication number
NO159169C
NO159169C NO823940A NO823940A NO159169C NO 159169 C NO159169 C NO 159169C NO 823940 A NO823940 A NO 823940A NO 823940 A NO823940 A NO 823940A NO 159169 C NO159169 C NO 159169C
Authority
NO
Norway
Prior art keywords
okso
benzopyrane
acetic acid
therapeutic activity
radical
Prior art date
Application number
NO823940A
Other languages
English (en)
Norwegian (no)
Other versions
NO823940L (no
NO159169B (no
Inventor
Philippe Briet
Jean-Jacques Berthelon
Francois Collonges
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of NO823940L publication Critical patent/NO823940L/no
Publication of NO159169B publication Critical patent/NO159169B/no
Publication of NO159169C publication Critical patent/NO159169C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO823940A 1981-11-25 1982-11-24 Analogifremgansmaate for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)eddiksyre med antitumoral terapeutisk aktivitet. NO159169C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8122020A FR2516922A1 (fr) 1981-11-25 1981-11-25 Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoiques, sels et derives, preparation et medicament les contenant

Publications (3)

Publication Number Publication Date
NO823940L NO823940L (no) 1983-05-26
NO159169B NO159169B (no) 1988-08-29
NO159169C true NO159169C (no) 1988-12-07

Family

ID=9264332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823940A NO159169C (no) 1981-11-25 1982-11-24 Analogifremgansmaate for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)eddiksyre med antitumoral terapeutisk aktivitet.

Country Status (24)

Country Link
US (2) US4602034A (hu)
EP (1) EP0080934B1 (hu)
JP (1) JPS5896082A (hu)
AT (1) ATE31927T1 (hu)
AU (1) AU563190B2 (hu)
CA (1) CA1213595A (hu)
CS (1) CS248035B2 (hu)
DD (1) DD204919A5 (hu)
DE (1) DE3277970D1 (hu)
DK (1) DK164163C (hu)
ES (1) ES8308323A1 (hu)
FR (1) FR2516922A1 (hu)
HU (1) HU192112B (hu)
IE (1) IE54130B1 (hu)
IL (1) IL67291A0 (hu)
IN (1) IN158843B (hu)
MA (1) MA19650A1 (hu)
MX (1) MX173498B (hu)
NO (1) NO159169C (hu)
NZ (1) NZ202596A (hu)
OA (1) OA07257A (hu)
SU (1) SU1250171A3 (hu)
YU (2) YU43726B (hu)
ZA (1) ZA828436B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536397A2 (en) * 1981-11-25 1984-05-25 Lipha [4-oxo-4H-1-Benzopyran-8-yl]alkanoic acids, their salts and derivatives, their preparation and medicinal products containing them
DE3311004A1 (de) * 1983-03-25 1984-09-27 Bayer Ag, 5090 Leverkusen Chromon- und thiochromon-8-aldehyde, sowie ein verfahren zu ihrer herstellung
JPS62215581A (ja) * 1986-03-18 1987-09-22 Koichi Shiyudo フラボンカルボン酸誘導体
IL85554A0 (en) * 1987-03-02 1988-08-31 Takeda Chemical Industries Ltd Chromone derivatives
IL89840A (en) * 1988-04-06 1996-10-31 Lipha Substituted flavonoid compounds and salts thereof their preparation and pharmaceutical composition containing them
USH1427H (en) * 1988-04-06 1995-04-04 Briet; Phillipe Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2
US5116954A (en) * 1988-04-06 1992-05-26 Lipha, Lyonnaise Industrielle Pharmaceutique Pharmaceutically useful flavonoic compounds containing at least one substituent on the benzopyranone ring moiety
US5126129A (en) * 1988-05-23 1992-06-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cancer therapy using interleukin-2 and flavone compounds
US5238954A (en) * 1989-01-19 1993-08-24 The Upjohn Company Fluorinated flavone acetic acid
JPH04502761A (ja) * 1989-01-19 1992-05-21 ジ・アップジョン・カンパニー フッ素化フラボン酢酸
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
EP1189611B1 (en) * 1999-06-14 2006-05-03 Cancer Research Technology Limited Cancer therapy
EP1218002A4 (en) 2000-01-24 2004-09-22 Jozef S Mruk USE OF FLAVON-8 ACETIC ACID IN VASCULAR AND CARDIOVASCULAR INTERVENTIONS AND ACUTE CORONARY SYNDROME
WO2002009700A1 (en) * 2000-07-28 2002-02-07 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) * 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) * 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) * 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
GB0321999D0 (en) * 2003-09-19 2003-10-22 Cancer Rec Tech Ltd Anti-cancer combinations
BRPI0614965A2 (pt) * 2005-08-26 2016-09-13 Antisoma Plc método para a modulação de crescimento neoplástico, usos de um composto ou, um sal, éster ou pró-droga farmaceuticamente aceitável do mesmo, de um aglutinante do fator de crescimento endotelial vascular, e de um taxano, formulação farmacêutica, e, kit
EP2470174A1 (en) 2009-08-27 2012-07-04 Merck Patent GmbH Use of faa and its derivatives in cosmetics and dermatology
CA3022722A1 (en) * 2009-11-05 2011-05-12 Rhizen Pharmaceuticals S.A. Pi3k protein kinase modulators
CN103304531A (zh) * 2013-06-25 2013-09-18 南方医科大学 一种3-芳基黄酮乙酸
JP2019507796A (ja) * 2016-03-11 2019-03-22 エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド イカリイン及びイカリチン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
US3350411A (en) * 1963-10-10 1967-10-31 Pharma Seceph S A Soc D Expl C Process for preparing 3-methylflavone-8-carboxylic acid
BE757821A (fr) * 1970-08-01 1971-04-01 Recordati Chem Pharm Procede de preparation de l'acide 3-propionyl-salicylique et dederives de cet acide
US4148900A (en) * 1973-12-27 1979-04-10 Carlo Erba S.P.A. 5:6-Benzo-γ-pyrone derivatives and process for their preparation
GB1479518A (en) * 1973-12-27 1977-07-13 Erba Carlo Spa 5,6-benzo-ypsilon-pyrone derivatives
FR2281112A1 (fr) * 1974-08-05 1976-03-05 Lipha Nouveau medicament choleretique et anti-inflammatoire
GB1469823A (en) * 1974-08-13 1977-04-06 Farma Lepori Flavone derivatives
DE2549745A1 (de) * 1974-11-20 1976-05-26 Lipha Durch einen chromonylrest substituierte propionsaeuren sowie deren derivate und verwendungen

Also Published As

Publication number Publication date
EP0080934A1 (fr) 1983-06-08
MX173498B (es) 1994-03-10
DK164163B (da) 1992-05-18
YU43726B (en) 1989-10-31
YU43675B (en) 1989-10-31
FR2516922A1 (fr) 1983-05-27
IN158843B (hu) 1987-01-31
CA1213595A (fr) 1986-11-04
IL67291A0 (en) 1983-03-31
NO823940L (no) 1983-05-26
ATE31927T1 (de) 1988-01-15
AU563190B2 (en) 1987-07-02
IE822752L (en) 1983-05-25
NO159169B (no) 1988-08-29
JPS5896082A (ja) 1983-06-07
DK523082A (da) 1983-05-26
EP0080934B1 (fr) 1988-01-13
CS248035B2 (en) 1987-01-15
SU1250171A3 (ru) 1986-08-07
JPH0214352B2 (hu) 1990-04-06
DE3277970D1 (en) 1988-02-18
FR2516922B1 (hu) 1984-02-10
DD204919A5 (de) 1983-12-14
HU192112B (en) 1987-05-28
MA19650A1 (fr) 1983-07-01
YU264982A (en) 1984-12-31
US4783533A (en) 1988-11-08
DK164163C (da) 1992-10-19
IE54130B1 (en) 1989-06-21
NZ202596A (en) 1986-02-21
ZA828436B (en) 1983-09-28
YU163084A (en) 1985-03-20
ES517637A0 (es) 1983-08-16
OA07257A (fr) 1984-04-30
ES8308323A1 (es) 1983-08-16
AU9073082A (en) 1983-06-02
US4602034A (en) 1986-07-22

Similar Documents

Publication Publication Date Title
NO159169C (no) Analogifremgansmaate for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)eddiksyre med antitumoral terapeutisk aktivitet.
BE836672A (fr) Procede de preparation d'acides organiques par hydrolyse biologique
ZA817696B (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl)alcanoic acids,salts and esters thereof,process for producing the same and these active agents containing pharmaceutical compounds
PT69582A (fr) Nouveaux acides lactame-n-acetiques et leurs amides leurs procedes de preparation et compositions pharmaceutiques
ZA817698B (en) N-benzoyl-omega-anilino alkane carboxylic acids,salts and esters thereof,process for producing the same and pharmaceutical preparations containing the same
FR2287452A1 (fr) Procede de preparation d'esters d'acides n-triorganosilyl-carbamiques
NO157734C (no) Fremgangsmaate ved fremstilling av (d)-2-(6-methoxy-2-nafthyl)-propionsyre og dens farmasoeytisk aksepterbare salter.
SE8405275D0 (sv) 1,2-dithiolan derivatives, processes for their production, pharmaceutical compositions containing them and their use
BE824908A (fr) Procede de preparation d'esters alkyliques d'acides beta-alcoxybutyriques
DE2964850D1 (en) Thienylbenzoic-acid derivatives, process for their production, and pharmaceutical preparations containing these compounds
BE825632A (fr) Procede de preparation d'esters alkyliques d'acides hydroxycarboxyliques aromatiques
NO812630L (no) Fremgangsmaate for fremstilling av alfa-substituert ureidobenzylpenicillan-syre
BE848498A (fr) Procede de preparation d'esters d'acides alcane-phosphoniques,
ES307804A1 (es) Procedimiento para la obtencion de esteres asimetricos del acido tiol o tionotiolfosforico
FR2315932A1 (fr) Derives d'acides quinoleine-carboxyliques et medicaments qui en contiennent
JPS527935A (en) Preparation of substituted phenylacetic acid derivatives
FR2276314A1 (fr) Procede de preparation d'esters dialcoyles d'acides 1-acyloxy-alcoylene-phosphoniques